Medicine: Managing aortic stenosis, Warning about a gout drug

Podcast
News from the World of Medicine
  • 2020 08, Medicine, Managing aortic stenosis, Warning about a gout drug
    29:25
audio
29:25 Min.
Medicine: Mediterranean diet
audio
29:25 Min.
Medicine: Corticosteroids for asthma
audio
29:25 Min.
Medicine: Away from aspirin?
audio
29:25 Min.
Medicine: Mild hypertension during pregnancy
audio
29:25 Min.
Medicine: CT coronary angiography
audio
29:25 Min.
Medicine: Vitamin D supplements do not work
audio
29:25 Min.
Medicine: Covid-19 in the year 2022
audio
29:25 Min.
Medicine: Treatment of outpatients with Covid-19
audio
29:25 Min.
Medicine: i.v. contrast media in kidney disease
audio
29:25 Min.
Medicine: Use of platelet-rich plasma

The first medical topic today:
Three clinical studies published in 2019 led to the conclusion either open-heart surgery or minimally invasive heart surgery will be used more often in the future in patients with aortic stenosis. The minimally invasive heart surgery for aortic stenosis is transcatheter aortic valve replacement. The three clinical studies published in 2019 showed that either open-heart surgery or minimally invasive heart surgery (that is, as mentioned, transcatheter aortic valve replacement for the patients with aortic stenosis), can now expand also to lower-risk patients.
The second medical news today:
A warning has been issued about a gout drug. The U.S. Food & Drug Administration (the FDA) has mandated that the drug febuxostat for patients with gout carries a boxed warning, I repeat, a boxed warning, in other words, a highly visible warning, to alert doctors and patients to the increased risk of death due to cardiovascular causes as a side effect of febuxostat.

Dokumente

2020 08, Medicine, Text, Managing aortic stenosis, Warning about a gout drug, PDF, 158.7 kB Download

Schreibe einen Kommentar